Indianapolis, IN. Opponents on the football field, a group of eleven schools from the Big Ten athletic conference have come together to launch an ambitious new effort against a common foe: cancer. Team Draft will have the opportunity to meet with the Big Ten Cancer Consortium and discuss what new developments they have been working on.
“This is a rare opportunity for the universities to work together as part of a regional team science initiative to advance cancer research,” said Patrick J. Loehrer Sr., MD, director of the Indiana University Melvin and Bren Simon Cancer Center. “The advantage of this, particularly during a time of austerity for research, is that we can build upon the strengths of the institutions and fortify some of the shortcomings.”
Newly developed clinical trials will be linked to molecular diagnostics, enabling researchers to understand what drives the cancers to grow and what might be done to stop them from growing.
“For research to be truly impactful, we must work together,” said Maha Hussain, MD, FACP, associate director of clinical research at the University of Michigan Comprehensive Cancer Center. “The synergy, the collaboration, the implementation all are aimed at one ultimate goal – making a real difference for patients.”
The 11 schools that comprise the Big Ten Cancer Research Consortium are: Indiana University, Northwestern University, Penn State University, Purdue University, Rutgers University, the University of Illinois, University of Iowa, University of Michigan, University of Minnesota, University of Nebraska, and University of Wisconsin.